Joint Base Lewis Mcchord, WASHINGTON3 Active Studies

PTSD Clinical Trials in Joint Base Lewis Mcchord, WASHINGTON

Find 3 actively recruiting ptsd clinical trials in Joint Base Lewis Mcchord, WASHINGTON. Connect with local research sites and explore new treatment options.

3
Active Trials
1
Sponsors
1,200
Enrolling

Recruiting PTSD Studies in Joint Base Lewis Mcchord

About PTSD Clinical Trials in Joint Base Lewis Mcchord

Post-traumatic stress disorder (PTSD) is a mental health condition triggered by experiencing or witnessing a traumatic event. Symptoms include flashbacks, nightmares, severe anxiety, and uncontrollable thoughts. Treatment includes trauma-focused psychotherapy and medications.

There are currently 3 ptsd clinical trials recruiting participants in Joint Base Lewis Mcchord, WASHINGTON. These studies are seeking a combined 1,200 participants. Research is being sponsored by Global Coalition for Adaptive Research. Clinical trial participation is free and participants receive study-related medical care at no cost.

PTSD Clinical Trials in Joint Base Lewis Mcchord — FAQ

Are there ptsd clinical trials in Joint Base Lewis Mcchord?

Yes, there are 3 ptsd clinical trials currently recruiting in Joint Base Lewis Mcchord, WASHINGTON. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Joint Base Lewis Mcchord?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Joint Base Lewis Mcchord research site will contact you about next steps.

Are clinical trials in Joint Base Lewis Mcchord free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Joint Base Lewis Mcchord studies also compensate for your time and travel.

What ptsd treatments are being tested?

The 3 active trials in Joint Base Lewis Mcchord are testing new therapies including novel drugs, biologics, and treatment approaches for ptsd.

Data updated March 2, 2026 from ClinicalTrials.gov